Two Sigma Investments’s Insulet PODD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-1,100
Closed -$293K 3960
2021
Q4
$293K Sell
1,100
-5,800
-84% -$1.68M ﹤0.01% 3659
2021
Q3
$1.96M Buy
6,900
+4,900
+245% +$1.4M ﹤0.01% 2012
2021
Q2
$549K Buy
+2,000
New +$544K ﹤0.01% 3011
2021
Q1
Sell
-2,400
Closed -$614K 4170
2020
Q4
$614K Sell
2,400
-500
-17% -$124K ﹤0.01% 2354
2020
Q3
$686K Sell
2,900
-700
-19% -$147K ﹤0.01% 2013
2020
Q2
$699K Buy
3,600
+400
+13% +$76.5K ﹤0.01% 1762
2020
Q1
$530K Buy
+3,200
New +$585K ﹤0.01% 1886

Other funds holding PODD

Two Sigma Investments's PODD Position: Q1 2026 in Review

Two Sigma Investments increased its Insulet (PODD) stake by 108% in Q1 2026, buying an estimated $99.4M and bringing the position to 762,349 shares worth $160M. The position accounts for 0.13% of the portfolio, ranked #181.

Two Sigma Investments first reported a position in PODD in Q2 2013 and has held it in 31 quarters since. 784 funds tracked by Wall St. Rank hold PODD as of Q1 2026.

  • Two Sigma Investments held 762,349 shares of Insulet worth $160M as of Q1 2026.
  • Two Sigma Investments bought 395,627 Insulet shares in Q1 2026, an estimated $99.4M.
  • Insulet made up 0.13% of Two Sigma Investments's portfolio in Q1 2026, its #181 holding.
  • Two Sigma Investments first reported a position in Insulet in Q2 2013 and has held it in 31 quarters since.
  • 784 funds tracked by Wall St. Rank held Insulet as of Q1 2026.

Based on Two Sigma Investments's 13F filing for Q1 2026, filed 15 May 2026.